Epitope spreading

Current Opinion in Immunology

Volumn 8, Issue 6, 1996, Pages 831-836

  Vanderlugt, Carol J ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; INFLAMMATION; MULTIPLE SCLEROSIS; PATHOGENESIS; REVIEW; T LYMPHOCYTE;

EID: 0030459801     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80012-4     Document Type: Article

References (35)

1. Oldstone MB: Molecular mimicry and autoimmune disease. Cell 1987, 50:819-920.
2. Gianani R, Sarvetnick N: Viruses, cytokines. antigens, and autoimmunity. Proc Natl Acad Sci USA 1996, 93:2257-2259.
3. Miller SD, Karpus WJ : The immunopathogenesis and regulation of T-cell mediated demyelmating diseases. Immunol Today 1994, 15:356-361.
4. Miller SD, McRae BL, Vanderlugt CL, Nikcevich KM, Pope JG, Pope L, Karpus WJ : Evolution of the T cell repertoire during the course of experimental autoimmune encephalomyelitis. Immunol Rev 1995, 144:225-244. The authors review evidence for epitope spreading to endogenous myelin epitopes in peptide induced R-EAE models in the SJL/J mouse and following infection with Theilers' murine encephalomyelitis virus.
5. Perry LL, Barzaga ME: Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis. J Immunol 1987, 138:1434-1441.
6. McCarron RM, Fallis RJ, McFarlin DE: Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol 1990, 29:73-79.
7. Perry LL, Barzaga Gilbert E, Trotter JL: T cell sensitization to proteolipid protein in myelin basic protein-induced experimental allergic encephalomyelitis. I Neuroimmunol 1991, 33:7-16.
8. Cross AH, Tuohy VK, Raine CS; Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol 1993, 146:261-269.
9. Lehmann PV, Forsthuber T, Miller A, Sercarz EE: Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen, Nature 1992, 358:155-157
10. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD: Functional evidence for epitope spreading in the relapsing pathology of EAE in the SJL/J mouse. J Exp Med 1995, 182:75-85. The authors show the involvement of inter molecular epitope spreading to PLP139-151 in MBP84-104-induced R-EAE and intramolecular epitope spreading to PLP178-191 in PLP139-151 -induced R-EAE. The extent of activation of relapse-associated epitopes was shown to correlate with the degree of tissue damage during acute disease. Splenic T cells specific for the relapse associated ephopes could transfer disease to naive mice and tolerance to the intact PLP protein during disease remission (which inhibited responses to both the initiating and relapse associated epitope) prevented disease relapses.
11. Zhao ML. Fritz RB: The immune response to a subdominant epitope in myelin basic protein exon-2 results in immunity to intra- and intermolecular dominant epitopes. J Neuroimmunol 1995, 61:179-184. The authors show that R-EAE induced by transfer of a T cell line specific for the product exon-2 of the MBP gene leads to R-EAE in the SJL/J mouse and the subsequent development of splenic prolilerative responses to MBPAc1-11, MBP43-88, MBP89-101, and PLP139-151, PLP139-151-specific lines derived from the recipient mice transferred R-EAE to naive recipients,
12. Jansson L, Diener P, Engstrom A, Olsson T, Holmdahl R: Spreading of the immune response to different myelin basic protein peptides in chronic experimental autoimmune encephalomyelitis in B10.RIII mice. Eur J Immunol 1995, 25:2195-2200. The authors show that induction of R-EAE in B10.RIII mice immunized with MBP89-101 eventually results in the development of interferon-producing T cells to peptides outside of this region.
13. Yu M, Johnson JM, Tuohy VK: A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J Exp Med 1996, 183:1777-1788. The authors determine the sequential pattern of epitope spreading in PLP139-151-induced R-EAE in the (SWR×SJL)F1 mouse and show that tolerance to the relapse-associated MBP37-99 epitope blocks disease progression.
14. Tan L-J, Kennedy MK, Dal Canto MC, Miller SD: Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance. J Immunol 1991, 147:1797-1802.
15. Miller SD, Vanderlugt CL, Lenschow DJ, Pope JG, Karandikar NJ, Dal Canto MC, Bluestone JA: Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995, 3:739-745. The authors show that treatment of SJL/J mice during remission from active PLP139-151-induced R-EAE with anti-B7-1 Fab fragments blocks the activation of T cell specific for the relapse-associated PLP178-191 epitope and inhibits expression of clinical relapses.
16. Samson MF, Smilek DE: Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes. J Immunol 1995, 155:2737-2746
17. Kautman DL. Clare-Salzler M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV Spontaneous loss of T cell tolerance to glutamic acid decarboxytase in murine insulin-dependent diabetes. Nature 1993, 366:69-72.
18. Tisch R. Yang XD, Singsr SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabatic mice. Nature 1993, 366:72-75.
19. Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996, 183:1561-1567. The authors show that intranasal tolerance to the proposed disease inducing epitope on GAD65 results in activation of Th2 cells which reduce the incidence of diabetes in NOD mice and blocks the activation of autoreactive T cell responses to other pancreatic β-cell antigens.
20. James JA, Gross T, Scofield RH, Harley JB: Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995, 181:453-461. The authors show in an experimental model of SLE that rabbits primed to Sm B/B′ peptides develop an SLE-like syndrome along with autoantibody responses to spliceosomal proteins other than Sm B/B′.
21. Topfer F, Gordon T, McCluskey J: Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Nalt Acad Sci USA 1995, 92:875-879. The authors show that, upon immunization of mice with a fragment of the La protein, autoantibody responses to other non-cross-reactive components of the La/Ro ribonucleoprotem complex are generated
22. Fujinami RS Oldstone MB: Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985, 230:1043-1045.
23. Scherer MT, Ignatowicz L, Winslow GM, Kappler JW, Marrack P: Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 1993, 9:101-128.
24. Liebert UG, Linington C, Ter Meulen V: Induction of autoimmune reactions to myelin basic protein in measles virus encephalitis in Lewis rats. J Neuroimmunol 1988, 17:103-118.
25. Liebert UG, Hashim GA, Ter Meulen V: Characterization of measles virus-induced cellular autoimmune reactions against myelin basic protein in Lewis rats. J Neumimmunol 1990, 29:139-147.
26. Ter Meulen V: Autoimmune reactions against myelin basic protein induced by corona and measles viruses. Ann NY Acad Sci 1998, 540:202-209.
27. Mokntarian F, Shi Y, Zhu PF, Grob D: Immune responses, and autoimmune outcome, during virus infection of the central nervous system. Cell Immunol 1994, 157:195-210.
28. Mokhtarian F, Grob D, Griffin DE: Role of the immune response in Sindbis virus-induced paralysis of SJL/J mice. J Immunol 1989, 143:633-637.
29. Miller SD, Gerety SJ: Immunologic aspects of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Semin Virol 1990, 1:263-272
30. Vaughan JH, Valbracht JR, Nguyen MD, Handley HH, Smith RS, Patrick K, Rhodes GH: Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J Clin Invest 1995, 95:1306-1316.
31. Vaughan JH, Nguyen MD, Valbracht JR, Patrick K, Rhodes GH: Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J Clin Invest 1995, 95:1316-1327.
32. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K: Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993, 11:729-766.
33. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G: Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993, 14:203-208.
34. Elson CJ, Barker RN, Thompson SJ, Williams NA: Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today 1995, 16:71-76.
35. Mamula MJ, Janeway CA Jr: Do B cells drive the diversification of immune responses? Immunol Today 1993, 14:151-154.